BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22648938)

  • 21. Hepatoblastoma: assessment of criteria for histologic classification.
    Rowland JM
    Med Pediatr Oncol; 2002 Nov; 39(5):478-83. PubMed ID: 12228903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An approach to handling pediatric liver tumors.
    Stocker JT
    Am J Clin Pathol; 1998 Apr; 109(4 Suppl 1):S67-72. PubMed ID: 9533750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics and epigenetics of hepatoblastoma.
    Tomlinson GE; Kappler R
    Pediatr Blood Cancer; 2012 Nov; 59(5):785-92. PubMed ID: 22807084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
    Buendia MA
    Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver tumors in children.
    Litten JB; Tomlinson GE
    Oncologist; 2008 Jul; 13(7):812-20. PubMed ID: 18644850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.
    Albrecht S; von Schweinitz D; Waha A; Kraus JA; von Deimling A; Pietsch T
    Cancer Res; 1994 Oct; 54(19):5041-4. PubMed ID: 7923113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic alterations in liver cell tumors as detected by comparative genomic hybridization.
    Terracciano L; Tornillo L
    Pathologica; 2003 Apr; 95(2):71-82. PubMed ID: 12768875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model.
    Armengol C; Cairo S; Fabre M; Buendia MA
    Int J Biochem Cell Biol; 2011 Feb; 43(2):265-70. PubMed ID: 19646548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
    Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
    Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current concepts in pediatric liver tumors.
    Emre S; Umman V; Rodriguez-Davalos M
    Pediatr Transplant; 2012 Sep; 16(6):549-63. PubMed ID: 22554057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric Liver Tumors: Updates in Classification.
    Cho SJ
    Surg Pathol Clin; 2020 Dec; 13(4):601-623. PubMed ID: 33183723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric liver tumors.
    Williams RA; Ferrell LD
    Pathology (Phila); 1993; 2(1):23-42. PubMed ID: 9420929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive allelotyping of hepatoblastoma.
    Terada Y; Matsumoto S; Bando K; Tajiri T
    Hepatogastroenterology; 2009; 56(89):199-204. PubMed ID: 19453057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
    Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
    J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver neoplasia in children.
    Hadzic N; Finegold MJ
    Clin Liver Dis; 2011 May; 15(2):443-62, vii-x. PubMed ID: 21689623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A perspective on the hepatoblastoma symposium.
    Ablin A; Plaschkes J
    Pediatr Blood Cancer; 2012 Nov; 59(5):775. PubMed ID: 22811018
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma.
    Matsunaga T; Sasaki F; Ohira M; Hashizume K; Hayashi A; Hayashi Y; Mugishima H; Ohnuma N;
    Pediatr Surg Int; 2003 May; 19(3):142-6. PubMed ID: 12768314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma.
    Pietsch T; Fonatsch C; Albrecht S; Maschek H; Wolf HK; von Schweinitz D
    Lab Invest; 1996 Apr; 74(4):809-18. PubMed ID: 8606490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.